[ALA] YoY Quarter Result on 30-Sep-2017 [#Q1]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
29-Sep-2017
Financial Year
2018
Quarter
30-Sep-2017 [#Q1]
Profit Trend
QoQ- -336.47%
YoY- -136.31%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 176 192 427 202 195 1,419 1,523 -30.18%
PBT -874 -3,850 -435 -1,113 -527 -906 -979 -1.87%
Tax 0 0 0 0 56 0 -6 -
NP -874 -3,850 -435 -1,113 -471 -906 -972 -1.75%
Tax Rate - - - - - - - -
Total Cost 1,050 4,041 862 1,315 666 2,325 2,495 -13.42%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -496.92 -2,008.97 -101.83 -551.87 -240.94 -63.82 -63.87 40.72%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.00 -0.03 -0.00 -0.02 -0.01 -0.02 -0.03 -
EPS Diluted -0.00 -0.03 -0.00 -0.02 -0.01 -0.02 -0.02 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.